{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:55:31Z","timestamp":1793166931132,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05481-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:34:09Z","timestamp":1762529649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Microbiota Dysbiosis in Amyotrophic Lateral Sclerosis: A Systematic Review of Human Studies"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4669-1527","authenticated-orcid":false,"given":"Priyanka","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8508-2740","authenticated-orcid":false,"given":"Ranjeet Kumar","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabesh","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-1308","authenticated-orcid":false,"given":"Gopal","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-1699","authenticated-orcid":false,"given":"Abhishek","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"10360","key":"5481_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363\u20131380","journal-title":"Lancet"},{"issue":"1","key":"5481_CR2","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, et al. (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3(1):1\u201319","journal-title":"Nat Rev Dis Primers"},{"issue":"9769","key":"5481_CR3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942\u2013955","journal-title":"Lancet"},{"issue":"4","key":"5481_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer F, B\u00e4ckhed F (2013) The gut microbiota\u2014masters of host development and physiology. Nat Rev Microbiol 11(4):227\u2013238","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"5481_CR5","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology 28(2):203","journal-title":"Annals of gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology"},{"key":"5481_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1118529","volume":"14","author":"K Kasarello","year":"2023","unstructured":"Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K (2023) Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol 14:1118529","journal-title":"Front Microbiol"},{"issue":"3","key":"5481_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-018-1856-5","volume":"136","author":"C Pellegrini","year":"2018","unstructured":"Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M (2018) Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 136(3):345\u2013361","journal-title":"Acta Neuropathol"},{"issue":"4","key":"5481_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer F, B\u00e4ckhed F (2013) The gut microbiota \u2014 masters of host development and physiology. Nat Rev Microbiol 11(4):227\u2013238. https:\/\/doi.org\/10.1038\/nrmicro2974","journal-title":"Nat Rev Microbiol"},{"key":"5481_CR9","unstructured":"Zhang, X.; Tang, B.; Guo, J. Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies."},{"key":"5481_CR10","unstructured":"Seo, D.-o.; Holtzman, D. M. Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies."},{"issue":"3","key":"5481_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031871","volume":"25","author":"A Lee","year":"2024","unstructured":"Lee A, Henderson R, Aylward J, McCombe P (2024) Gut symptoms, gut dysbiosis and gut-derived toxins in ALS. Int J Mol Sci 25(3):1871","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5481_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"A Parker","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR (2020) Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut microbes 11(2):135\u2013157","journal-title":"Gut microbes"},{"issue":"1","key":"5481_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2102878","volume":"14","author":"H Ahmed","year":"2022","unstructured":"Ahmed H, Leyrolle Q, Koistinen V, K\u00e4rkk\u00e4inen O, Lay\u00e9 S, Delzenne N, Hanhineva K (2022) Microbiota-derived metabolites as drivers of gut\u2013brain communication. Gut microbes 14(1):2102878","journal-title":"Gut microbes"},{"issue":"24","key":"5481_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244038","volume":"11","author":"M Kalyan","year":"2022","unstructured":"Kalyan M, Tousif AH, Sonali S, Vichitra C, Sunanda T, Praveenraj SS, Ray B, Gorantla VR et al (2022) Role of endogenous lipopolysaccharides in neurological disorders. Cells 11(24):4038","journal-title":"Cells"},{"issue":"1","key":"5481_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki H, Ueyama J, Ito M, Hamaguchi T, Takimoto K, Maeda T, Kashihara K, Tsuboi Y et al (2024) Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. NPJ Parkinsons Dis 10(1):106","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"5481_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1808","volume":"7","author":"P Prajjwal","year":"2024","unstructured":"Prajjwal P, Inban P, Sai VP, Shiny KS, Lam JR, John J, Sulaimanov M, Tekuru Y et al (2024) The effects of the interplay between vitamins, antibiotics, and gut microbiota on the pathogenesis and progression of dementia: a systematic review and meta-analysis. Health Sci Rep 7(1):e1808","journal-title":"Health Sci Rep"},{"issue":"1","key":"5481_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","volume":"56","author":"D-O Seo","year":"2024","unstructured":"Seo D-O, Holtzman DM (2024) Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies. Exp Mol Med 56(1):86\u201394","journal-title":"Exp Mol Med"},{"issue":"3","key":"5481_CR18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00415-023-12107-0","volume":"271","author":"C-C Tsai","year":"2024","unstructured":"Tsai C-C, Jette S, Tremlett H (2024) Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review. J Neurol 271(3):1108\u20131123","journal-title":"J Neurol"},{"issue":"1","key":"5481_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J (2023) Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener 12(1):59","journal-title":"Transl Neurodegener"},{"issue":"7","key":"5481_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/00207454.2019.1702549","volume":"130","author":"AC Erber","year":"2020","unstructured":"Erber AC, Cetin H, Berry D, Schernhammer ES (2020) The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review. Int J Neurosci 130(7):727\u2013735","journal-title":"Int J Neurosci"},{"key":"5481_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5481_CR22","unstructured":"Wells, G. A.; Shea, B.; O\u2019Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000."},{"issue":"7770","key":"5481_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","volume":"572","author":"E Blacher","year":"2019","unstructured":"Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C et al (2019) Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572(7770):474\u2013480","journal-title":"Nature"},{"key":"5481_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2017.09.023","volume":"61","author":"D Brenner","year":"2018","unstructured":"Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph AC, Weishaupt JH (2018) The fecal microbiome of ALS patients. Neurobiol Aging 61:132\u2013137","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5481_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01607-9","volume":"18","author":"D Di Gioia","year":"2020","unstructured":"Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, Gagg\u00eca F, Lucenti MA et al (2020) A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med 18(1):153","journal-title":"BMC Med"},{"key":"5481_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01479","volume":"7","author":"X Fang","year":"2016","unstructured":"Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, Chen T (2016) Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol 7:1479. https:\/\/doi.org\/10.3389\/fmicb.2016.01479","journal-title":"Front Microbiol"},{"issue":"2","key":"5481_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7555\/JBR.36.20220198","volume":"37","author":"Z Gong","year":"2022","unstructured":"Gong Z, Ba L, Tang J, Yang Y, Li Z, Liu M, Yang C, Ding F, et al. (2022) Gut microbiota links with cognitive impairment in amyotrophic lateral sclerosis: a multi-omics study. J Biomed Res 37(2):125","journal-title":"J Biomed Res"},{"issue":"2","key":"5481_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awad306","volume":"147","author":"K Guo","year":"2024","unstructured":"Guo K, Figueroa-Romero C, Noureldein MH, Murdock BJ, Savelieff MG, Hur J, Goutman SA, Feldman EL (2024) Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis. Brain 147(2):665\u2013679","journal-title":"Brain"},{"issue":"1\u20132","key":"5481_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21678421.2021.1904994","volume":"23","author":"VS Hertzberg","year":"2022","unstructured":"Hertzberg VS, Singh H, Fournier CN, Moustafa A, Polak M, Kuelbs CA, Torralba MG, Tansey MG et al (2022) Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls. Amyotroph Lateral Scler Frontotemporal Degener 23(1\u20132):91\u201399","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"5481_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02586-5","volume":"22","author":"HS Kim","year":"2022","unstructured":"Kim HS, Son J, Lee D, Tsai J, Wang D, Chocron ES, Jeong S, Kittrell P et al (2022) Gut-and oral-dysbiosis differentially impact spinal-and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol 22(1):62","journal-title":"BMC Neurol"},{"issue":"02","key":"5481_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/CM9.0000000000002701","volume":"137","author":"K Liu","year":"2024","unstructured":"Liu K, Guo Q, Ding Y, Luo L, Huang J, Zhang Q (2024) Alterations in nasal microbiota of patients with amyotrophic lateral sclerosis. Chin Med J 137(02):162\u2013171","journal-title":"Chin Med J"},{"key":"5481_CR32","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1097\/MCG.0000000000001042","volume":"52","author":"L Mazzini","year":"2018","unstructured":"Mazzini L, Mogna L, De Marchi F, Amoruso A, Pane M, Aloisio I, Cionci NB, Gagg\u00eca F et al (2018) Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J Clin Gastroenterol 52:S68\u2013S70","journal-title":"J Clin Gastroenterol"},{"issue":"7\u20138","key":"5481_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/21678421.2020.1772825","volume":"21","author":"ST Ngo","year":"2020","unstructured":"Ngo ST, Restuadi R, McCrae AF, Van Eijk RP, Garton F, Henderson RD, Wray NR, McCombe PA et al (2020) Progression and survival of patients with motor neuron disease relative to their fecal microbiota. Amyotroph Lateral Scler Frontotemporal Degener 21(7\u20138):549\u2013562","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"7","key":"5481_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9070753","volume":"9","author":"E Niccolai","year":"2021","unstructured":"Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, Martinelli I, Menicatti M et al (2021) The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity? Biomedicines 9(7):753","journal-title":"Biomedicines"},{"issue":"3\u20134","key":"5481_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","volume":"22","author":"K Nicholson","year":"2021","unstructured":"Nicholson K, Bjornevik K, Abu-Ali G, Chan J, Cortese M, Dedi B, Jeon M, Xavier R et al (2021) The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 22(3\u20134):186\u2013194","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"5481_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.55730\/1300-0144.5825","volume":"54","author":"Z \u00d6zaydin Aksun","year":"2024","unstructured":"\u00d6zaydin Aksun Z, Erdo\u011fan S, Kalkanci A, \u015eahin EA, \u00c7uhadar T, \u015eener H\u00d6 (2024) Is gut microbiota of patients with ALS different from that of healthy individuals? Turk J Med Sci 54(3):579\u2013587","journal-title":"Turk J Med Sci"},{"issue":"7","key":"5481_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-02806-8","volume":"79","author":"G Quaranta","year":"2022","unstructured":"Quaranta G, Mandrioli J, Bibb\u00f2 S, Guarnaccia A, Fancello G, Simonini C, Amedei A, Niccolai E et al (2022) Rummeliibacillus suwonensis: first time isolation from human feces by culturomics. Curr Microbiol 79(7):197","journal-title":"Curr Microbiol"},{"issue":"18","key":"5481_CR38","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13443","volume":"5","author":"J Rowin","year":"2017","unstructured":"Rowin J, Xia Y, Jung B, Sun J (2017) Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep 5(18):e13443","journal-title":"Physiol Rep"},{"issue":"1","key":"5481_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69845-8","volume":"10","author":"Q Zeng","year":"2020","unstructured":"Zeng Q, Shen J, Chen K, Zhou J, Liao Q, Lu K, Yuan J, Bi F (2020) The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci Rep 10(1):12998","journal-title":"Sci Rep"},{"issue":"15","key":"5481_CR40","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/CM9.0000000000000351","volume":"132","author":"C-D Zhai","year":"2019","unstructured":"Zhai C-D, Zheng J-J, An B-C, Huang H-F, Tan Z-C (2019) Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses. Chin Med J 132(15):1815\u20131822","journal-title":"Chin Med J"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:34:15Z","timestamp":1762529655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5481"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05481-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"10"}}